BEIGENE, LTD. AMENDMENT NO. 2 TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 17th, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 2 (this “Amendment”) to the SHARE PURCHASE AGREEMENT, dated as of October 31, 2019, as amended on December 6, 2019 (the “Agreement”), is made and entered into as of March 17, 2020, by and among BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
